Fidelity Disruptive Medicine ETF
FMED
6 hedge funds and large institutions have $31.1M invested in Fidelity Disruptive Medicine ETF in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.29% more ownership
Funds ownership: 61.84% → 62.13% (+0.29%)
4% less capital invested
Capital invested by funds: $32.3M → $31.1M (-$1.23M)
25% less funds holding
Funds holding: 8 → 6 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$722K |
| 2 |
Jane Street
New York
|
+$12.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$570K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.18K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $15.1M | -$570K | -22,576 | -3% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $14.5M | +$722K | +28,597 | +5% |
|
|
3
Jane Street
New York
| $1.57M | +$12.6K | +499 | +0.8% |
|
|
PSFG
4
Park Square Financial Group
Roswell,
Georgia
| $13.9K | – | – | – |
|
|
CPBTD
5
Central Pacific Bank - Trust Division
Honolulu,
Hawaii
| $2.29K | – | – | – |
|
|
GEA
6
Glen Eagle Advisors
Kingston,
New Jersey
| $2.13K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$5.18K | -210 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$4K | -162 | Closed |
|
FMED Hedge Fund Activity: Q1 2025 in Review
6 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q1 2025, worth a combined $31.1M — down 3.8% from $32.3M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of FMED and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Wealth Enhancement Advisory Services, adding an estimated $722K. The largest seller was Fidelity Investments, cutting an estimated $570K.
- 6 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q1 2025, down from 8 in Q4 2024.
- Funds reported $31.1M of Fidelity Disruptive Medicine ETF stock for Q1 2025, down 3.8% quarter-over-quarter.
- 0 funds opened new Fidelity Disruptive Medicine ETF positions in Q1 2025 and 2 closed out, a net change of -2 holders.
- The largest Fidelity Disruptive Medicine ETF buyer in Q1 2025 was Wealth Enhancement Advisory Services, an estimated $722K added.
- The largest Fidelity Disruptive Medicine ETF seller in Q1 2025 was Fidelity Investments, an estimated $570K sold.
Based on aggregated 13F filings for Q1 2025.